Citation: | BIAN Guifeng, LI Xiaodong, HE Song, ZHANG Bin, LI Jiaojiao. The predictive value of MRI-DWI-IVIM multiparameter imaging in tumor infiltrating lymphocyte levels after neoadjuvant chemotherapy for invasive breast cancer[J]. Chinese Journal of General Practice, 2024, 22(10): 1746-1749. doi: 10.16766/j.cnki.issn.1674-4152.003725 |
[1] |
TAURIN S, ALKHALIFA H. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses[J]. Neoplasia, 2020, 22(12): 663-678. doi: 10.1016/j.neo.2020.09.009
|
[2] |
CHEN W, WEI W, YU L, et al. Mammary development and breast cancer: a notch perspective[J]. J Mammary Gland Biol Neoplasia, 2021, 26(3): 309-320. doi: 10.1007/s10911-021-09496-1
|
[3] |
IWAMOTO T, KAJIWARA Y, ZHU Y, et al. Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer[J]. Chin Clin Oncol, 2020, 9(3): 27-38. doi: 10.21037/cco.2020.01.06
|
[4] |
FERNANDES I, SCORSATO A, KALIKS R, et al. Tumor-infiltrating lymphocytes in HER2-Low breast cancer[J]. Clin Breast Cancer, 2023, 23(7): 470-479. doi: 10.1016/j.clbc.2023.07.007
|
[5] |
SU GH, XIAO Y, JIANG L, et al. Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer[J]. J Transl Med, 2022, 20(1): 471-483. doi: 10.1186/s12967-022-03688-x
|
[6] |
韩佳雯, 苏婷婷, 徐元兵, 等. 肿瘤浸润淋巴细胞在三阴性乳腺癌新辅助化疗预测价值中的研究进展[J]. 中国肿瘤临床, 2023, 50(19): 1011-1016. doi: 10.12354/j.issn.1000-8179.2023.20230567
HAN J W, SU T T, XU Y B, et al. Research progress of tumor infiltrating lymphocytes in predicting the efficacy of neo-adjuvant chemotherapy for triple negative breast cancer[J]. Chinese Journal of Clinical Oncology, 2023, 50(19): 1011-1016. doi: 10.12354/j.issn.1000-8179.2023.20230567
|
[7] |
李崇, 杨勇, 徐成春, 等. DCE-MRI在乳腺良性病变与乳腺癌诊断中的应用价值[J]. 保健医学研究与实践, 2024, 21(3): 82-88.
LI C, YANG Y, XU C C, et al. The value of DCE-MRI in the diagnosis of benign breast lesions and breast cancer[J]. Health Medicine Research and Practice, 2024, 21(3): 82-88.
|
[8] |
DIECI M V, RADOSEVIC-ROBIN N, FINEBERG S, et al. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: a report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer[J]. Semin Cancer Biol, 2018, 52(Pt 2): 16-25.
|
[9] |
CHEN Y, KLINGEN T A, AAS H, et al. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis[J]. J Pathol Clin Res, 2023, 9(3): 151-164. doi: 10.1002/cjp2.309
|
[10] |
王希梅, 蒲倩, 耿文文, 等. 肿瘤浸润淋巴细胞比例与乳腺癌临床病理特征和预后的关系[J]. 中国现代普通外科进展, 2022, 25(10): 782-785, 789.
WANG XM, PU Q, GENG WW, et al. Relationship between tumor infiltrating lymphocytes and clinicopathological features and prognosis in patients with breast cancer[J]. Chinese Journal of Current Advances in General Surgery, 2022, 25(10): 782-785, 789.
|
[11] |
贺松, 李娇娇, 张斌, 等. 分析NAC治疗乳腺癌的MRI成像变化及其参数对预测浸润性乳腺癌TILs水平的效能[J]. 中国CT和MRI杂志, 2023, 21(7): 87-89, 92.
HE S, LI JJ, ZHANG B, et al. To Analyze the MRI Changes of NAC in Breast Cancer Treatment and the Efficacy of Its Parameters in Predicting TILs Level in Invasive Breast Cancer[J]. Chinese Journal of CT and MRI, 2023, 21(7): 87-89, 92.
|
[12] |
陈翠, 金叶, 王琳, 等. 30例乳腺化生性癌的多种影像学对比分析[J]. 上海交通大学学报(医学版), 2022, 42(1): 70-76.
CHEN C, JIN Y, WANG L, et al. Comparative analysis of 30 cases of metaplastic carcinoma of the breast[J]. Journal of Shanghai Jiaotong University(Medical Science), 2022, 42(1): 70-76.
|
[13] |
康锋, 代凤霞. 乳腺癌组织中孕激素受体、人表皮生长因子受体-2检测联合动态增强磁共振成像对乳腺癌术后复发时间的预测价值[J]. 陕西医学杂志, 2022, 51(11): 1437-1440, 1452.
KANG F, DAI F X. Prediction value of progesterone receptor and human epidermal growth factor receptor-2 detection combined with dynamic enhanced magnetic resonance imaging for postoperative recurrence of breast cancer[J]. Shaanxi Medical Journal, 2022, 51(11): 1437-1440, 1452.
|
[14] |
KANG H S, KIM J Y, KIM J J, et al. Diffusion kurtosis MR imaging of invasive breast cancer: correlations with prognostic factors and molecular subtypes[J]. J Magn Reson Imaging, 2022, 56(1): 110-120. doi: 10.1002/jmri.27999
|
[15] |
孟庆涛, 李军, 蒋会东, 等. VI-RADS联合IVIM序列在膀胱癌肌层侵犯评估中的价值[J]. 中华全科医学, 2022, 20(12): 2096-2100. doi: 10.16766/j.cnki.issn.1674-4152.002778
MENG QT, LI J, JIANG HD, et al. Value of vesical imaging reporting and data system combined with intravoxel incoherent motion sequences in the evaluation of muscle invasion in bladder cancer[J]. Chinese Journal of General Practice, 2022, 20(12): 2096-2100. doi: 10.16766/j.cnki.issn.1674-4152.002778
|
[16] |
HONDA M, IIMA M, KATAOKA M, et al. Biomarkers predictive of distant disease-free survival derived from diffusion-weighted imaging of breast cancer[J]. Magn Reson Med Sci, 2023, 22(4): 469-476.
|
[17] |
LIU Y, LUO H, WANG C, et al. Diagnostic performance of T2-weighted imaging and intravoxel incoherent motion diffusion-weighted MRI for predicting metastatic axillary lymph nodes in T1 and T2 stage breast cancer[J]. Acta Radiol, 2022, 63(4): 447-457.
|
[18] |
JIN Y N, ZHANG Y, CHENG J L, et al. The role of histogram analysis in diffusion-weighted imaging in the differential diagnosis of benign and malignant breast lesions[J]. BMC Med Inform Decis Mak, 2020, 20(1): 239-249.
|
[19] |
蒋伟, 邓虹, 张翔, 等. 体素内不相干运动扩散加权成像在乳腺癌腋窝转移性小淋巴结中的研究价值[J]. 磁共振成像, 2023, 14(9): 70-75, 80.
JIANG W, DENG H, ZHANG X, et al. Clinical value of intravoxel incoherent motion diffusion-weighted imaging in the diagnosis of small metastatic axillary lymph nodes in breast cancer[J]. Chinese Journal of Magnetic Resonance Imaging, 2023, 14(9): 70-75, 80.
|